Skip to main content
VSI Technologies

Documentation velocity for organisations that run on evidence.

Quality documentation, deviation handling, regulatory submission assembly and lab-record hygiene, automated inside a validated environment.

Industry overview

Inside a pharma & biotech operation

Everything must be documented, and the documenting competes with the science. Deviations, change controls, batch records and submissions each carry defined workflows whose elapsed time is dominated by assembly and routing.

A regulated life-sciences operation produces documents as its second product. The quality system defines who writes, reviews and approves each one; the burden is not the decision but the assembly, pulling the history, the references and the prior art into a reviewable package.

The workforce feels it as context-switching: scientists and quality professionals hired for judgement spending hours as document couriers between systems that do not talk.

Common challenges

Challenges we see across pharma & biotech

If three or more are true, the rest of this page is about your operation.

  • Deviation closure times are measured in weeks and the queue is aging
  • Change controls wait on document assembly rather than on decisions
  • Submission teams rebuild reference packages that exist somewhere already
  • Batch-record review is a bottleneck before release
  • Training records are chased manually before every audit

How we help

Five practices, applied to pharma & biotech

AI, cloud, cybersecurity, hardware and programme delivery, one integrated bench, each practice applied to how pharma & biotech actually operates.

  1. Agents for the documentation burden GxP creates: deviation and CAPA record assembly in the QMS, batch-record review support that flags what a reviewer must see, regulatory-submission document collation, and training-record chasing, always as assistance inside your validated process, never as an uncontrolled change to it.

  2. Infrastructure that survives validation: environments qualified and documented, LIMS and MES integrations under change control, and data pipelines built for ALCOA+ data-integrity expectations, attributable, legible, contemporaneous, original, accurate.

  3. Security for data whose integrity is the product: access controls that map to data-integrity requirements, lab-instrument networks segmented from the office, and audit trails protected as rigorously as the batch record itself.

  4. Lab and plant compute under qualification discipline: instrument workstations specified to vendor requirements, changes documented for your CSV files, and end-of-life handled so no regulated data leaves on a forgotten drive.

  5. Projects run to GxP change control: computerised-system validation planned into the schedule rather than bolted on, impact assessments before work begins, and documentation an auditor can walk without a guide.

Where we start

Automation candidates

Deliberately mundane. The impressive-sounding workflow is rarely the one worth doing first.

  • Deviation and CAPA file assembly
  • Change-control package preparation
  • Batch-record review support
  • Submission document assembly
  • Training and audit-readiness record checks

Systems we integrate with here

If you run one of these, this is the conversation.

  • Quality management systems
  • Document management systems
  • LIMS
  • MES and batch systems
  • Regulatory information management

Our solutions

How we transform pharma & biotech operations

What happens today, what changes, and what to watch for as each workflow is automated.

Deviation and CAPA file assembly

Today
The owner assembles history, impact references and prior deviations by hand before assessment can start.
After
The file arrives assembled with linked history; the owner starts at the assessment and the approver at the decision.
What to watch
The assembly must cite, not summarise, a quality decision made on a paraphrase is a finding.

Batch-record review support

Today
Reviewers page through records hunting exceptions.
After
Exceptions are surfaced with their context; reviewers spend their time on the exceptions rather than the paging.
What to watch
Review-by-exception must be validated as such, with the sampling logic documented in the quality system.

Submission document assembly

Today
Teams rebuild modules from source documents under deadline.
After
Modules assemble from the document management system with lineage, and authors write rather than collate.
What to watch
Version discipline is everything; the agent must always be able to say which version fed which module.

The operating picture

Where the agent layer sits in the quality loop

Your operating loop todayThe agent layer we deploy into it
01

Event

Deviations and complaints enter the QMS from every direction.

Agent layer

Captures complete initial records and routes by your classification rules, so investigations start same-day.

02

Investigate

Root-cause work needs history: batches, equipment, prior events.

Agent layer

Assembles the investigation file from LIMS, MES and the historian, every source cited, nothing re-keyed.

03

Act

CAPAs generate tasks, owners and due dates across departments.

Agent layer

Tracks every action to its owner and deadline, and escalates the ones drifting toward overdue.

04

Verify

Effectiveness checks and closure need evidence, on schedule.

Agent layer

Compiles the closure package, evidence, signatures, timeline, ready for quality’s final disposition.

Event, investigation, action, verification, the CAPA loop that regulators read first. Agents assemble records and chase signatures; quality decisions and dispositions stay with qualified people, inside the validated process.

Platforms and systems

Technology we work with in pharma & biotech

The systems of record this sector runs on, and why each one matters to a deployment.

Quality management systems
The workflow engine of the operation, and the place automation must integrate rather than bypass.
LIMS
Where lab truth lives; read patterns are straightforward, and write access is deliberately rare.
Document management systems
Version and lineage discipline here decides whether assembled packages are trustworthy.

The constraint

What makes this sector harder

The environment is validated, so every change is a controlled change.

Computerised systems in this sector operate under validation, and automation joins that regime rather than escaping it: intended use documented, risk assessed, and the human decision points explicit. The pattern that works treats validation as a design input.

Data integrity expectations, attributable, legible, contemporaneous, original, accurate, apply to what the automation writes as much as to what people write.

Gloved hands pipetting into a tube inside a laboratory cabinet.

Compliance

Compliance that shapes pharma & biotech deployments

The regimes your organisation operates under, and what each one constrains in a deployment. We design to these from the first architecture diagram, they describe your obligations rather than our credentials, and VSI's own position publishes only once it is substantiated.

GxP and data-integrity expectations
Everything the automation records must be attributable and reconstructable; that shapes logging from day one.
Computerised-system validation
Deployment cadence follows change control; the design anticipates it rather than fighting it.

How we work with public-sector and regulated buyers

Success stories

Results in pharma & biotech

Engagements in this sector, with the figures drawn from project records under a named attestation, and the method behind every number on its own page.

All case studies, filterable by sector

The first month

What starting looks like

What actually happens, week by week. Note where the design conversations sit, before the build, not after it.

  1. 01Week 1

    Baseline one quality queue, deviations or change controls, separating assembly time from decision time

    Baseline one quality queue, deviations or change controls, separating assembly time from decision time.

  2. 02Weeks 2-3

    Automate file assembly on one site’s queue inside the existing QMS workflow, validation documents in hand

    Automate file assembly on one site’s queue inside the existing QMS workflow, validation documents in hand.

  3. 03Week 4

    Review closure-time movement with quality leadership and take the widen-or-stop decision

    Review closure-time movement with quality leadership and take the widen-or-stop decision.

Next step

A free 20-minute pharma & biotech assessment

Scheduling, intake and clinical documentation, against your record system.

No preparation required and nothing to install. Bring the workflow that costs you the most hours; leave with a view of what we would automate first, what it depends on, and what we would not touch.

Book the free assessment

Questions

Asked often enough to answer here

Can this live inside a validated environment?
That is the operating assumption. The deployment produces the validation documentation with the build, and the human decision points are explicit in both.
Does the agent write to the QMS?
It assembles and drafts inside the workflow; entries are attributed and the record shows what was automated. What must be a person stays a person.
What about submissions to regulators?
The agent assembles and version-controls; authorship and approval remain with your regulatory team. Assembly is where the weeks go, so that is where the return is.
Can AI be used at all under our quality system?
Yes - as a documented, validated tool with people on the quality decisions. Regulators have signalled openness to automation in assembly and review support precisely when its intended use is defined and its outputs are attributable, which is the only pattern we deploy.
What about our data staying in-region?
Data residency is a design input gathered in week one. Where the requirement is in-region or on-premises processing, the deployment follows it, and the data-flow documentation shows it.